NurExone Announces the Transfer of Manufacturing of the Active Element in ExoPTEN Drug to a Commercial GMP Manufacturer
01 août 2024 16h04 HE
|
NurExone Biologic Inc
NurExone Announces the Transfer of Manufacturing of the Active Element in ExoPTEN Drug to a Commercial GMP Manufacturer
Longeveron® Presents Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ in Mild Alzheimer’s Disease at the Alzheimer’s Association International Conference® (AAIC)
28 juil. 2024 16h51 HE
|
Longeveron
Longeveron Phase 2a clinical results in Alzheimer's Disease selected for Featured Research oral presentation at Alzheimer’s Association International Conf
Tissue Engineering Market Size is Expected to Reach USD 12.43 Billion by 2032, Growing at a CAGR of 14.40%: Straits Research
18 juil. 2024 10h20 HE
|
Straits Research Private Limited - Garner Insights
New York, United States, July 18, 2024 (GLOBE NEWSWIRE) -- As per the Latest Report by Straits Research, the global tissue engineering market size was valued at USD 4,333.61 million in 2023. It is...
Gene Therapy Agreements Analysis Report and Directory 2024: Comprehensive Listing of 740 Deals Announced Since 2016
17 juil. 2024 05h31 HE
|
Research and Markets
Dublin, July 17, 2024 (GLOBE NEWSWIRE) -- The "Gene Therapy Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Gene Therapy Collaboration and...
Regenerative Medicine Market to Surpass USD 83.6 Billion by 2031 | Skyquest Technology
12 juil. 2024 09h06 HE
|
SkyQuest Technology Consulting Pvt. Ltd.
Westford, USA, July 12, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the global regenerative medicine market will attain a value of USD 83.6 billion by 2031, with a CAGR of 27.2% during the...
California Institute for Regenerative Medicine (CIRM) Appoints New CEO
10 juil. 2024 15h30 HE
|
California Institute for Regenerative Medicine (CIRM)
South San Francisco, California, July 10, 2024 (GLOBE NEWSWIRE) -- The Independent Citizens’ Oversight Committee (ICOC), the governing board of the California Institute for Regenerative Medicine...
Longeveron® Announces U.S. FDA Grants Lomecel-B™ Regenerative Medicine Advanced Therapy (RMAT) Designation for the Treatment of Mild Alzheimer’s Disease
10 juil. 2024 07h30 HE
|
Longeveron
Longeveron® Announces U.S. FDA Grants Lomecel-B(TM) Regenerative Medicine Advanced Therapy (RMAT) Designation for the Treatment of Mild Alzheimer’s Disease
Cell Therapy Packaging Market, 2035 - 48% Vials and 67% Plastic Products, with EVA and Polypropylene Leading Fabrication Materials
10 juil. 2024 07h28 HE
|
Research and Markets
Dublin, July 10, 2024 (GLOBE NEWSWIRE) -- The "Cell Therapy Packaging Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Therapy Packed, Package Engineering Design,...
Neha Motwani Elected to Longeveron® Board of Directors
09 juil. 2024 09h00 HE
|
Longeveron
Neha Motwani, a senior healthcare investment banker, has been elected to the Longeveron Board of Directors
Gene Therapy Pioneer Roger Hajjar, MD, Elected to Longeveron® Board of Directors
08 juil. 2024 09h00 HE
|
Longeveron
Gene therapy pioneer Dr. Roger Hajjar elected to Longeveron Board of Directors as company advances it novel cellular therapy across multiple indications.